QURE News

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

The Gross Law Firm Reminds uniQure Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026 - QURE

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.

Holzer & Holzer, LLC Reminds QURE Investors of the April 13, 2026 Lead Plaintiff Deadline in the uniQure N.V. Securities Class Action

QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

ROSEN, A LONGSTANDING LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

Pomerantz LLP Calls Attention to Class Action Against uniQure N.V. – QURE

ROSEN, A TOP RANKED LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

Shareholders that lost money on uniQure N.V.(QURE) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More